MicroRNA miR-320a modulates induction of HO-1, GCLM and OKL38 by oxidized phospholipids in endothelial cells

Atherosclerosis

Volumn 235, Issue 1, 2014, Pages 1-8

  Schrottmaier, Waltraud C ^a   Oskolkova, Olga V ^a   Schabbauer, Gernot ^a   Afonyushkin, Taras ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Electrophilic stress response; GCLM; HO 1; MicroRNA 320a; NRF2; OKL38; Oxidized phospholipids

Indexed keywords

GLUTAMATE CYSTEINE LIGASE; GLUTATHIONE CYSTEINE LIGASE MODIFYING SUBUNIT; HEME OXYGENASE 1; MICRORNA; MICRORNA 320A; OXIDATIVE STRESS INDUCED GROWTH INHIBITOR 1; OXIDIZED PALMITOYL ARACHIDONOYL PHOSPHATIDYLCHOLINE; PHOSPHOLIPID; POLYETHYLENEIMINE; TRANSCRIPTION FACTOR NRF2; UNCLASSIFIED DRUG; APOLIPOPROTEIN E; GCLM PROTEIN, MOUSE; GLUTAMATE-CYSTEINE LIGASE MODIFIER SUBUNIT, HUMAN; ISOTHIOCYANIC ACID DERIVATIVE; MESSENGER RNA; MIRN320 MICRORNA, HUMAN; MIRN320 MICRORNA, MOUSE; NFE2L2 PROTEIN, HUMAN; OKL38 PROTEIN, HUMAN; OKL38 PROTEIN, RAT; OLIGONUCLEOTIDE; OXYGEN; PROTEIN; SULFORAFAN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIOXIDANT RESPONSIVE ELEMENT; AORTA ATHEROSCLEROSIS; ARTICLE; ATHEROGENIC DIET; CELL PROTECTION; CONTROLLED STUDY; DISEASE COURSE; DNA BINDING; ELECTROPHILIC STRESS; ELECTROSPRAY MASS SPECTROMETRY; ENDOTHELIUM CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; GENETIC TRANSFECTION; LIPID OXIDATION; MALE; MOUSE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; RECEPTOR UPREGULATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; THIN LAYER CHROMATOGRAPHY; UBIQUITINATION; UMBILICAL VEIN ENDOTHELIAL CELL; WESTERN BLOTTING; ANIMAL; C57BL MOUSE; CHEMISTRY; DNA MICROARRAY; FEMALE; GENETICS; HUMAN; METABOLISM;

ANIMALS; APOLIPOPROTEINS E; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GLUTAMATE-CYSTEINE LIGASE; HEME OXYGENASE-1; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; ISOTHIOCYANATES; MALE; MICE; MICE, INBRED C57BL; MICRORNAS; NF-E2-RELATED FACTOR 2; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; OLIGONUCLEOTIDES; OXIDATIVE STRESS; OXYGEN; PHOSPHOLIPIDS; PROTEINS; RNA, MESSENGER; TRANSFECTION;

EID: 84901842092     PISSN: 00219150     EISSN: 18791484     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2014.03.026     Document Type: Article

References (33)

1. Lee S., Birukov K.G., Romanoski C.E., Springstead J.R., Lusis A.J., Berliner J.A. Role of phospholipid oxidation products in atherosclerosis. Circ Res 2012, 111:778-799.
2. Oskolkova O.V., Afonyushkin T., Preinerstorfer B., Bicker W., von S.E., Hainzl E., et al. Oxidized phospholipids are more potent antagonists of lipopolysaccharide than inducers of inflammation. JImmunol 2010, 185:7706-7712.
3. Jyrkkanen H.K., Kansanen E., Inkala M., Kivela A.M., Hurttila H., Heinonen S.E., et al. Nrf2 regulates antioxidant gene expression evoked by oxidized phospholipids in endothelial cells and murine arteries invivo. Circ Res 2008, 103:e1-e9.
4. Li R., Chen W., Yanes R., Lee S., Berliner J.A. OKL38 is an oxidative stress response gene stimulated by oxidized phospholipids. JLipid Res 2007, 48:709-715.
5. Wu M.L., Ho Y.C., Yet S.F. Acentral role of heme oxygenase-1 in cardiovascular protection. Antioxid Redox Signal 2011, 15:1835-1846.
6. Callegari A., Liu Y., White C.C., Chait A., Gough P., Raines E.W., et al. Gain and loss of function for glutathione synthesis: impact on advanced atherosclerosis in apolipoprotein E-deficient mice. Arterioscler Thromb Vasc Biol 2011, 31:2473-2482.
7. Li R. OKL38 is an oxidative stress response gene stimulated by oxidized phospholipids 2007.
8. Giudice A., Arra C., Turco M.C. Review of molecular mechanisms involved in the activation of the Nrf2-ARE signaling pathway by chemopreventive agents. Methods Mol Biol 2010, 647:37-74.
9. Lau A., Villeneuve N.F., Sun Z., Wong P.K., Zhang D.D. Dual roles of Nrf2 in cancer. Pharmacol Res 2008, 58:262-270.
10. Eades G., Yang M., Yao Y., Zhang Y., Zhou Q. miR-200a regulates Nrf2 activation by targeting Keap1 mRNA in breast cancer cells. JBiol Chem 2011, 286:40725-40733.
11. Pulkkinen K.H., Yla-Herttuala S., Levonen A.L. Heme oxygenase 1 is induced by miR-155 via reduced BACH1 translation in endothelial cells. Free Radic Biol Med 2011, 51:2124-2131.
12. Yang M., Yao Y., Eades G., Zhang Y., Zhou Q. MiR-28 regulates Nrf2 expression through a Keap1-independent mechanism. Breast Cancer Res Treat 2011, 129:983-991.
13. Tang H., Lee M., Sharpe O., Salamone L., Noonan E.J., Hoang C.D., et al. Oxidative stress-responsive microRNA-320 regulates glycolysis in diverse biological systems. FASEB J 2012, 26:4710-4721.
14. Paine A., Eiz-Vesper B., Blasczyk R., Immenschuh S. Signaling to heme oxygenase-1 and its anti-inflammatory therapeutic potential. Biochem Pharmacol 2010, 80:1895-1903.
15. Watson A.D., Leitinger N., Navab M., Faull K.F., Horkko S., Witztum J.L., et al. Structural identification by mass spectrometry of oxidized phospholipids in minimally oxidized low density lipoprotein that induce monocyte/endothelial interactions and evidence for their presence invivo. JBiol Chem 1997, 272:13597-13607.
16. Baker A., Saltik M., Lehrmann H., Killisch I., Mautner V., Lamm G., et al. Polyethylenimine (PEI) is a simple, inexpensive and effective reagent for condensing and linking plasmid DNA to adenovirus for gene delivery. Gene Ther 1997, 4:773-782.
17. Bochkov V.N., Oskolkova O.V., Birukov K.G., Levonen A.L., Binder C.J., Stockl J. Generation and biological activities of oxidized phospholipids. Antioxid Redox Signal 2010, 12:1009-1059.
18. Schroen B., Heymans S. Small but smart-microRNAs in the centre of inflammatory processes during cardiovascular diseases, the metabolic syndrome, and ageing. Cardiovasc Res 2012, 93:605-613.
19. Afonyushkin T., Oskolkova O.V., Bochkov V.N. Permissive role of miR-663 in induction of VEGF and activation of the ATF4 branch of unfolded protein response in endothelial cells by oxidized phospholipids. Atherosclerosis 2012, 225:50-55.
20. Romanoski C.E., Che N., Yin F., Mai N., Pouldar D., Civelek M., et al. Network for activation of human endothelial cells by oxidized phospholipids: a critical role of heme oxygenase 1. Circ Res 2011, 109:e27-e41.
21. Nguyen T., Sherratt P.J., Nioi P., Yang C.S., Pickett C.B. Nrf2 controls constitutive and inducible expression of ARE-driven genes through a dynamic pathway involving nucleocytoplasmic shuttling by Keap1. JBiol Chem 2005, 280:32485-32492.
22. Berliner J.A., Leitinger N., Tsimikas S. The role of oxidized phospholipids in atherosclerosis. JLipid Res 2009, 50(Suppl.):S207-S212.
23. Kadl A., Huber J., Gruber F., Bochkov V.N., Binder B.R., Leitinger N. Analysis of inflammatory gene induction by oxidized phospholipids invivo by quantitative real-time RT-PCR in comparison with effects of LPS. Vasc Pharmacol 2002, 38:219-227.
24. Boring L., Gosling J., Cleary M., Charo I.F. Decreased lesion formation in CCR2-/- mice reveals a role for chemokines in the initiation of atherosclerosis. Nature 1998, 394:894-897.
25. Wang L.J., Lee T.S., Lee F.Y., Pai R.C., Chau L.Y. Expression of heme oxygenase-1 in atherosclerotic lesions. Am J Pathol 1998, 152:711-720.
26. Ramos-Gomez M., Kwak M.K., Dolan P.M., Itoh K., Yamamoto M., Talalay P., et al. Sensitivity to carcinogenesis is increased and chemoprotective efficacy of enzyme inducers is lost in nrf2 transcription factor-deficient mice. Proc Natl Acad Sci U S A 2001, 98:3410-3415.
27. Chen X.L., Dodd G., Kunsch C. Sulforaphane inhibits TNF-alpha-induced activation of p38 MAP kinase and VCAM-1 and MCP-1 expression in endothelial cells. Inflamm Res 2009, 58:513-521.
28. Oskolkova O.V., Afonyushkin T., Leitner A., von S.E., Gargalovic P.S., Lusis A.J., et al. ATF4-dependent transcription is a key mechanism in VEGF up-regulation by oxidized phospholipids: critical role of oxidized sn-2 residues in activation of unfolded protein response. Blood 2008, 112:330-339.
29. Afonyushkin T., Oskolkova O.V., Philippova M., Resink T.J., Erne P., Binder B.R., et al. Oxidized phospholipids regulate expression of ATF4 and VEGF in endothelial cells via NRF2-dependent mechanism: novel point of convergence between electrophilic and unfolded protein stress pathways. Arterioscler Thromb Vasc Biol 2010, 30:1007-1013.
30. Gupte A.A., Lyon C.J., Hsueh W.A. Nuclear factor (Erythroid-Derived 2)-Like-2 factor (Nrf2), a key regulator of the antioxidant response to protect against atherosclerosis and Nonalcoholic Steatohepatitis. Curr Diab Rep 2013.
31. Chapple S.J., Siow R.C., Mann G.E. Crosstalk between Nrf2 and the proteasome: therapeutic potential of Nrf2 inducers in vascular disease and aging. Curr Diab Rep 2013, 13:362-371.
32. Berliner J.A., Gharavi N.M. Endothelial cell regulation by phospholipid oxidation products. Free Radic Biol Med 2008, 45:119-123.
33. Huber J., Furnkranz A., Bochkov V.N., Patricia M.K., Lee H., Hedrick C.C., et al. Specific monocyte adhesion to endothelial cells induced by oxidized phospholipids involves activation of cPLA2 and lipoxygenase. JLipid Res 2006, 47:1054-1062.